By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ARTES Biotechnology 

Elisabeth-Selbert-Str. 9

Langenfeld    40764  Germany
Phone: 49-0-2173-27587-0 Fax: 49-0-2173-27587-77



Company News
ARTES Biotechnology Received Next Grant Of Patent For METAVAX 8/10/2017 10:37:08 AM
ARTES Biotechnology And BioSun Announce Co-Development For HPV Vaccine 11/4/2016 10:44:02 AM
ARTES Biotechnology And Burnet Institute Join Forces To Develop Novel Hepatitis C Vaccine 7/26/2016 9:17:41 AM
ARTES Biotechnology And Boehringer Ingelheim Animal Health Announce Collaboration 3/16/2015 10:37:42 AM
ARTES Biotechnology, InstrAction And Q-Biologicals Join Forces For Veterinary Vaccine Development 10/6/2014 8:12:17 AM
Malaria Transmission-blocking Vaccines – ARTES Biotechnology And Burnet Announced A Development Project 7/29/2014 8:50:14 AM
ARTES Biotechnology Release: TA101 GOCLIN European Funded Project For The Development Of An Innovative Product For The Treatment Of Rheumatoid Arthritis – 1,7M€ Total Budget 12/23/2013 10:45:50 AM
ARTES Biotechnology and Bio Farma Announce Collaboration in Vaccine Development 7/15/2013 9:39:49 AM
ARTES Biotechnology and Midas Pharma GmbH Signed Cooperation Contract 6/24/2013 9:37:08 AM
ARTES Biotechnology Issued New Patent in Australia for VLP Technology 4/22/2013 10:38:33 AM